China authorizes Livzon Pharma’s COVID-19 vaccine for emergency use
New protein-based vaccine to be used as booster jab, local media reports.
Abone Ol
China has approved Livzon Pharmaceutical Group's COVID-19 vaccine for emergency use, local media reported on Saturday.
Livzon’s protein-based vaccine is the eighth domestically developed vaccine that will be used as a booster shot in the country where nearly 90% of the population have received their primary vaccinations, according to Caixin Global’s website.
Most Read News
-
UK condemns Israeli minister's comments proposing
-
Italy's president criticizes Musk for 'interfering' with
-
South Korea mulling more support for Ukraine due to
-
Polls close after millions vote to elect new parliament
-
Path of war in Ukraine has direct repercussions in other
-
Former FARC leaders in Colombia accused of forcing
-
16 people killed by landslide in western Madagascar
-
Republicans to retain control of US House of Representat
-
US Muslim group declares Biden a ‘war criminal’ for
-
Global diabetes cases double to over 800M in 30 years
